Recent Publications on Vascular Endothelial Growth Factor Receptor-3: |  |
| The role of vascular endothelial growth factors and their receptors in malignant melanomas.
| 30th August, 2008
| Laboratory of Molecular Pathology and Department of Pathology, Faculty of
|
Lymphoedema and cellulitis: chicken or egg?
Vascular endothelial growth factors (VEGFs) have a leading role among...
Direct Link | 21st August, 2008
|
|
| Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?
| 21st August, 2008
| Third Department of Surgery, General Hospital of Athens G.Gennimatas
|
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Solid tumors express a range of factors required to sustain their growth...
Direct Link | 19th August, 2008
| Molecular/Cancer Biology Laboratory, Biomedicum Helsinki and Ludwig
|
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
PURPOSE: To assess the safety and efficacy of sunitinib in patients with...
Direct Link | 15th August, 2008
| Department of Solid Tumor Oncology and Urology, Cleveland Clinic Taussig
|
Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.
Lymphatic vessels play an important role in the regulation of tissue fluid...
Direct Link | 13th August, 2008
| Molecular/Cancer Biology Laboratory, Haartman Institute, Biomedicum
|
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
Angiogenesis, the growth of new blood vessels from pre-existing...
Direct Link | 12th August, 2008
| Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer
|
Molecular control of lymphatic metastasis.
The metastatic spread of tumor cells is the most lethal aspect of cancer...
Direct Link | 4th July, 2008
| Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria
|
Markers for microscopic imaging of lymphangiogenesis and angiogenesis.
Imaging of lymphangiogenesis and angiogenesis requires robust and...
Direct Link | 4th July, 2008
| Cardiovascular Research Institute, Comprehensive Cancer Center, and
|
Prox-1 Promotes Invasion of Kaposiform Hemangioendotheliomas.
Kaposi's sarcoma (KS) is the most frequently occurring malignant tumor in...
Direct Link | 27th June, 2008
| [1] 1Department of Dermatology, Cutaneous Biology Research Center, Boston,
|
Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells.
Kaposi's sarcoma (KS) is the most common tumor of AIDS patients worldwide....
Direct Link | 27th June, 2008
| Molecular and Cellular Biology Program, University of Washington, Seattle,
|
Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells.
Solid tumors express a range of factors required to sustain their growth...
Direct Link | 20th June, 2008
|
|
VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.
Solid tumors express a range of factors required to sustain their growth...
Direct Link | 20th June, 2008
|
|
Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
PURPOSE: To analyze whether tyrosine kinase inhibitors blocking VEGF...
Direct Link | 10th June, 2008
| Department of Ophthalmology, Friedrich-Alexander University
|
Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Vascular endothelial growth factor-C (VEGF-C) and its receptor, vascular...
Direct Link | 29th April, 2008
| Department of Pathology, Hallym University, Anyang, Republic of Korea.
|
